Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Franchini

Showing results (51-60 of 748) with videos related to

Pageof 75
Sort By:
Blood Transfusion = Trasfusione Del Sangue|August 16, 2011
The use of desmopressin in acquired haemophilia A: a systematic reviewMassimo Franchini, Giuseppe Lippi
Journal of Cellular and Molecular Medicine|February 21, 2009
Are haemophiliacs protected against cancer development? Prospective controlled studies are neededMassimo Franchini, Giuseppe Lippi
Transfusion|February 7, 2022
SARS-CoV-2 and the safety of blood donations: Time for a brave revision?Daniele Focosi, Massimo Franchini
Journal of Thrombosis and Thrombolysis|November 6, 2010
Acquired factor V inhibitors: a systematic reviewMassimo Franchini, Giuseppe Lippi
European Journal of Applied Physiology|September 17, 2009
Intermittent hypoxic training: doping or what?Giuseppe Lippi, Massimo Franchini
Seminars in Thrombosis and Hemostasis|July 16, 2010
Recombinant activated factor VII: mechanisms of action and current indicationsMassimo Franchini, Giuseppe Lippi
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 9, 2023
Polyclonal immunoglobulins for COVID-19 pre-exposure prophylaxis in immunocompromised patientsDaniele Focosi, Massimo Franchini
Hematology (Amsterdam, Netherlands)|July 16, 2005
Hereditary hemochromatosisMassimo Franchini, Dino Veneri
Thrombosis and Haemostasis|December 8, 2004
Are only haemophiliacs protected against ischemic heart disease?Massimo Franchini, Dino Veneri
Recenti Progressi in Medicina|February 20, 2002
[The new frontiers of blood doping]Giuseppe Lippi, Massimo Franchini
Pageof 75

Showing results (51-60 of 748) with videos related to

Sort By:
Pageof 75
Blood Transfusion = Trasfusione Del Sangue|August 16, 2011
The use of desmopressin in acquired haemophilia A: a systematic reviewMassimo Franchini, Giuseppe Lippi
Journal of Cellular and Molecular Medicine|February 21, 2009
Are haemophiliacs protected against cancer development? Prospective controlled studies are neededMassimo Franchini, Giuseppe Lippi
Transfusion|February 7, 2022
SARS-CoV-2 and the safety of blood donations: Time for a brave revision?Daniele Focosi, Massimo Franchini
Journal of Thrombosis and Thrombolysis|November 6, 2010
Acquired factor V inhibitors: a systematic reviewMassimo Franchini, Giuseppe Lippi
European Journal of Applied Physiology|September 17, 2009
Intermittent hypoxic training: doping or what?Giuseppe Lippi, Massimo Franchini
Seminars in Thrombosis and Hemostasis|July 16, 2010
Recombinant activated factor VII: mechanisms of action and current indicationsMassimo Franchini, Giuseppe Lippi
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 9, 2023
Polyclonal immunoglobulins for COVID-19 pre-exposure prophylaxis in immunocompromised patientsDaniele Focosi, Massimo Franchini
Hematology (Amsterdam, Netherlands)|July 16, 2005
Hereditary hemochromatosisMassimo Franchini, Dino Veneri
Thrombosis and Haemostasis|December 8, 2004
Are only haemophiliacs protected against ischemic heart disease?Massimo Franchini, Dino Veneri
Recenti Progressi in Medicina|February 20, 2002
[The new frontiers of blood doping]Giuseppe Lippi, Massimo Franchini
Pageof 75